Carvana Co vs Definium Therapeutics Inc. Common Shares — how do they compare? Carvana Co trades at $63.73 (market cap $69.55B), while Definium Therapeutics Inc. Common Shares trades at $36.9 (market cap $4.59B). The key difference: Carvana Co is far larger — about 15.2× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Carvana Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Carvana Co for 28 Days and Definium Therapeutics Inc. Common Shares for 0 Days on average.
| CVNA | DFTX | |
|---|---|---|
Market Cap | $69.55B | $4.59B |
Volume | 7,671,750 | 2,103,937 |
Sector | Consumer Cyclical | Health |
52-Week High | $95.69 | $48.45 |
52-Week Low | $56.27 | $10.68 |
Typical Hold Time | 28 Days | 0 Days |
Enterprise Value | $72.04B | $3.55B |
Signals from Pluang's Aura AI — not financial advice
Carvana (CVNA) trades at $63.21, up 0.72% with strong fundamental momentum including 10 consecutive quarters of record profitability. Revenue surged 52% in Q2 FY26 to $20.32B annually, while net income reached $1.41B with a 6.26% margin. Technical indicators show bearish momentum with key support at $61-62, though RSI levels remain neutral. The company continues expanding capacity to meet robust demand, with same-day delivery recently launched in Minneapolis.
CVNA presents growth potential with analyst consensus target of $84.07 (33% upside), but faces risks from high debt levels ($5.26B long-term) and volatile cash flow patterns. The stock's elevated P/E of 33.44 and EV/EBITDA of 507.31 suggest premium valuation, requiring sustained execution to justify. Competitive pressures in online auto retail and interest rate sensitivity remain key watchpoints for investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage.
Read more on CVNA →Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →